Doyle Thomas James

EDGAR CIK 0001910331

Kura Oncology, Inc. - KURA

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Officer
SVP, Finance & Accounting
Direct Buys
0
$0
0 Shares
Direct Sells
3
($130,297)
-14,029 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
11/14/2025
11/14/2025
Sell
-4,539 @ $11.18
 ($50,732) 130,257 (-3.37%) Direct
09/29/2025
09/29/2025
Sell
-4,541 @ $8.94
 ($40,607) 109,829 (-3.97%) Direct
01/28/2025
01/28/2025
Sell
-4,949 @ $7.87
 ($38,958) 88,193 (-5.31%) Direct